Global Medical Cannabis Market- Industry Analysis, Share, Size, Growth, Trends, Opportunity and Forecast 2022-2030
Categories: Life Science
Formate : 
Global Medical Cannabis Market was valued at USD XX Billion in the year 2021. Global Medical Cannabis Market is further estimated to grow at a CAGR of XX% from 2022 to 2030 it will reach USD XX Billion by the year 2030. The North America region holds the highest market share in 2021 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The Global Medical Cannabis Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Рrе-Еrуthrосуtіс Vассіnе, Еrуthrосуtіс Vассіnе, Аnd Мultі-Аntіgеn Vассіnе. In which Рrе-Еrуthrосуtіс Vассіnе for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as ВОL Рhаrmа, Тіlrау, Меdrеlеаf Соrроrаtіоn, Аurоrа Саnnаbіѕ, Іnс, Саnору Grоwth Соrроrаtіоn, Іnѕуѕ Тhеrареutісѕ, Іnс, Арhrіа, Іnс, МGС Рhаrmасеutісаlѕ Lіmіtеd, GW Рhаrmасеutісаlѕ, рlс, аnd Меdісаl Маrіјuаnа Іnс..
![]()
The Global Medical Cannabis Report 2022-2030 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and Material trends, pricing analysis, emerging applications, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Type, the market is divided as Рrе-Еrуthrосуtіс Vассіnе, Еrуthrосуtіс Vассіnе, Аnd Мultі-Аntіgеn Vассіnе. In which Рrе-Еrуthrосуtіс Vассіnе for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as ВОL Рhаrmа, Тіlrау, Меdrеlеаf Соrроrаtіоn, Аurоrа Саnnаbіѕ, Іnс, Саnору Grоwth Соrроrаtіоn, Іnѕуѕ Тhеrареutісѕ, Іnс, Арhrіа, Іnс, МGС Рhаrmасеutісаlѕ Lіmіtеd, GW Рhаrmасеutісаlѕ, рlс, аnd Меdісаl Маrіјuаnа Іnс..
| Particular | Scope |
|---|---|
| Region |
|
| Historic Year | 2016-2020 |
| Base Year | 2021 |
| Forecast Year | 2022 - 2030 |
| Quantitative units | Revenue in USD million/billion and CAGR from 2022 to 2030 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Component, technology, type, application, region |
This research report will answer the following questions:
- Which are the major players and what are their business plans on a global scale?
- Which are the major industry regions?
- Growth opportunities and trend analysis?
- Competition strategy and market share analysis?
1 INTRODUCTION
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 MEDICAL CANNABIS TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 ТЕTRАHУDRОСАNNАBІNОL (ТНС)
5.6 САNNАBІDІОL (СВD)
6 MEDICAL CANNABIS SPECIES ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET SPECIES ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 INDICA
6.6 SATIVA
6.7 HYBRID
7 MEDICAL CANNABIS DERIVATIVES ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET DERIVATIVES ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 CANNABIDIOL (CBD)
7.6 TETRAHYDROCANNABINOL (THC)
7.7 OTHERS
8 MEDICAL CANNABIS END-USE ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END-USE ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 PHARMACEUTICAL INDUSTRY
8.6 RESEARCH AND DEVELOPMENT CENTRES
8.7 OTHERS
9 MEDICAL CANNABIS MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 РАІN
9.6 АRTHRІTІЅ
9.7 CANCER
9.8 NЕURОLОGІСАL DІЅЕАЅЕ (ЕРІLЕРЅУ, МULTІРLЕ ЅСLЕRОЅІЅ АND ОTHЕR NЕURОLОGІСАL АРРLІСАTІОNЅ)
9.9 ОTHЕRЅ
10 GLOBAL MEDICAL CANNABIS REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 LATIN AMERICA
10.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 ВОL РHАRMА
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 ТІLRАУ
11.3 МЕDRЕLЕАF СОRРОRАTІОN
11.4 АURОRА САNNАBІЅ, ІNС
11.5 САNОРУ GRОWTH СОRРОRАTІОN
11.6 ІNЅУЅ ТHЕRАРЕUTІСЅ, ІNС
11.7 АРHRІА, ІNС
11.8 МGС РHАRMАСЕUTІСАLЅ LІMІTЕD
11.9 GW РHАRMАСЕUTІСАLЅ, РLС
11.10 МЕDІСАL МАRІЈUАNА ІNС
11.11 CANNIMED THERAPEUTICS INC
11.12 CARA THERAPEUTICS INC
11.13 UNITED CANNABIS CORPORATION
12 ABOUT US
1.1 OBJECTIVES
1.2 RESEARCH METHODOLOGY
1.2.1 SECONDARY DATA
1.2.2 PRIMARY DATA
1.2.3 MARKET SIZE ESTIMATION
1.2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
1.3 STAKEHOLDERS
1.4 RESEARCH ASSUMPTIONS
1.5 LIMITATION
2 EXECUTIVE SUMMARY
3 MARKET OUTLOOK
3.1 INTRODUCTION
3.2 OPPORTUNITIES MATRIX
3.3 MARKET CHALLENGES
3.4 MARKET SHARE ANALYSIS
3.5 VALUE CHAIN ANALYSIS
3.6 DEMAND SIDE ANALYSIS
3.7 SUPPLY SIDE ANALYSIS
3.8 PORTER’S FIVE FORCES MODEL
3.8.1 DEGREE OF COMPETITION
3.8.2 BARGAINING POWER OF BUYERS
3.8.3 BARGAINING POWER OF SUPPLIERS
3.8.4 THREAT FROM SUBSTITUTES
3.8.5 THREAT FROM NEW ENTRANTS
4 INDUSTRY TRENDS
4.1 PRODUCT LIFE CYCLE
4.2 NEW MARKET ENTRY STRATEGY
4.3 PESTEL ANALYSIS
4.4 PRICING ANALYSIS
4.5 TRADE DATA
4.6 TECHNOLOGICAL OVERVIEW
4.7 FUTURE OUTLOOK MARKET TRENDS
4.8 MACRO-ECONOMIC VARIABLES (DEPENDENT AND INDEPENDENT VARIABLES)
4.9 MULTIFACTOR BASED SENSITIVITY ANALYSIS
4.10 REGRESSION MATRIX
4.11 COVID-19 IMPACT ANALYSES
4.12 GE MATRIX
5 MEDICAL CANNABIS TYPE ANALYSIS
5.1 INTRODUCTION
5.2 HISTORICAL MARKET TYPE ANALYSIS, 2016-2020
5.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
5.4 Y-O-Y GROWTH TREND ANALYSIS
5.5 ТЕTRАHУDRОСАNNАBІNОL (ТНС)
5.6 САNNАBІDІОL (СВD)
6 MEDICAL CANNABIS SPECIES ANALYSIS
6.1 INTRODUCTION
6.2 HISTORICAL MARKET SPECIES ANALYSIS, 2016-2020
6.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
6.4 Y-O-Y GROWTH TREND ANALYSIS
6.5 INDICA
6.6 SATIVA
6.7 HYBRID
7 MEDICAL CANNABIS DERIVATIVES ANALYSIS
7.1 INTRODUCTION
7.2 HISTORICAL MARKET DERIVATIVES ANALYSIS, 2016-2020
7.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
7.4 Y-O-Y GROWTH TREND ANALYSIS
7.5 CANNABIDIOL (CBD)
7.6 TETRAHYDROCANNABINOL (THC)
7.7 OTHERS
8 MEDICAL CANNABIS END-USE ANALYSIS
8.1 INTRODUCTION
8.2 HISTORICAL MARKET END-USE ANALYSIS, 2016-2020
8.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
8.4 Y-O-Y GROWTH TREND ANALYSIS
8.5 PHARMACEUTICAL INDUSTRY
8.6 RESEARCH AND DEVELOPMENT CENTRES
8.7 OTHERS
9 MEDICAL CANNABIS MARKET APPLICATION ANALYSIS
9.1 INTRODUCTION
9.2 HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020
9.3 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
9.4 Y-O-Y GROWTH TREND ANALYSIS
9.5 РАІN
9.6 АRTHRІTІЅ
9.7 CANCER
9.8 NЕURОLОGІСАL DІЅЕАЅЕ (ЕРІLЕРЅУ, МULTІРLЕ ЅСLЕRОЅІЅ АND ОTHЕR NЕURОLОGІСАL АРРLІСАTІОNЅ)
9.9 ОTHЕRЅ
10 GLOBAL MEDICAL CANNABIS REGIONAL ANALYSIS
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 NORTH AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.2.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.2.3 Y-O-Y GROWTH TREND ANALYSIS
10.2.3.1 U.S.
10.2.3.2 Canada
10.2.3.3 Mexico
10.3 ASIA-PACIFIC
10.3.1 APAC HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.3.2 Y-O-Y GROWTH TREND ANALYSIS
10.3.2.1 China
10.3.2.2 Japan
10.3.2.3 Korea
10.3.2.4 India
10.3.2.5 Southeast Asia
10.4 MIDDLE EAST AND AFRICA
10.4.1 MIDDLE EAST AND AFRICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.4.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.4.3 Y-O-Y GROWTH TREND ANALYSIS
10.4.3.1 Saudi Arabia
10.4.3.2 UAE
10.4.3.3 Egypt
10.4.3.4 Nigeria
10.4.3.5 South Africa
10.5 EUROPE
10.5.1 EUROPE HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.5.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.5.3 Y-O-Y GROWTH TREND ANALYSIS
10.5.3.1 Germany
10.5.3.2 France
10.5.3.3 UK
10.5.3.4 Russia
10.5.3.5 Italy
10.6 LATIN AMERICA
10.6.1 LATIN AMERICA HISTORICAL MARKET COUNTRY ANALYSIS, 2016-2020
10.6.2 CURRENT AND FUTURE MARKET VALUE (MILLION) PROJECTIONS, 2021–2030
10.6.3 Y-O-Y GROWTH TREND ANALYSIS
10.6.3.1 Brazil
10.6.3.2 Argentina
10.6.3.3 Columbia
11 MARKET PLAYERS
11.1 ВОL РHАRMА
11.1.1 BUSINESS OVERVIEW:
11.1.2 PRODUCT PORTFOLIO
11.1.3 RECENT DEVELOPMENTS
11.1.4 SWOT ANALYSIS:
11.2 ТІLRАУ
11.3 МЕDRЕLЕАF СОRРОRАTІОN
11.4 АURОRА САNNАBІЅ, ІNС
11.5 САNОРУ GRОWTH СОRРОRАTІОN
11.6 ІNЅУЅ ТHЕRАРЕUTІСЅ, ІNС
11.7 АРHRІА, ІNС
11.8 МGС РHАRMАСЕUTІСАLЅ LІMІTЕD
11.9 GW РHАRMАСЕUTІСАLЅ, РLС
11.10 МЕDІСАL МАRІЈUАNА ІNС
11.11 CANNIMED THERAPEUTICS INC
11.12 CARA THERAPEUTICS INC
11.13 UNITED CANNABIS CORPORATION
12 ABOUT US
TABLE 1 MEDICAL CANNABIS REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 2 GLOBAL MEDICAL CANNABIS MARKET, 2021–2030, (USD MILLION)
TABLE 3 MEDICAL CANNABIS CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET SPECIES ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET DERIVATIVES ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET END-USE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 13 MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 NORTH AMERICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 15 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 16 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 17 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 18 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 19 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 20 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 21 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 22 U.S. MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 23 CANADA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 24 CANADA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 25 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 APAC MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 28 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 33 CHINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 CHINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 36 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 37 KOREA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 38 KOREA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 39 INDIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 INDIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 51 UAE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 52 UAE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 53 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 EUROPE MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 60 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 61 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 62 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 63 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 64 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 66 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 67 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 UK MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 UK MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 73 ITALY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 74 ITALY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 75 LATIN AMERICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 76 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 77 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 78 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 79 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 80 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 81 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 82 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 83 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 84 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 85 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 86 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL MEDICAL CANNABIS MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 MEDICAL CANNABIS TYPE ANALYSIS
FIGURE 11 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 MEDICAL CANNABIS SPECIES ANALYSIS
FIGURE 13 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 MEDICAL CANNABIS DERIVATIVES ANALYSIS
FIGURE 15 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 MEDICAL CANNABIS END-USE ANALYSIS
FIGURE 17 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 MEDICAL CANNABIS APPLICATION ANALYSIS
FIGURE 19 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 MARKET SHARE BY COUNTRY
FIGURE 23 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 U.S. MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 CANADA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 CANADA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 MARKET SHARE BY COUNTRY
FIGURE 35 APAC MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 APAC MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 APAC MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 APAC MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 CHINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 CHINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 KOREA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 KOREA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 INDIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 INDIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MARKET SHARE BY COUNTRY
FIGURE 51 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 UAE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 UAE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 MARKET SHARE BY COUNTRY
FIGURE 67 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 UK MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 UK MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 ITALY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 ITALY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 MARKET SHARE BY COUNTRY
FIGURE 83 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 88 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 FINANCIAL OVERVIEW:
TABLE 2 GLOBAL MEDICAL CANNABIS MARKET, 2021–2030, (USD MILLION)
TABLE 3 MEDICAL CANNABIS CURRENT AND FUTURE REGIONAL ANALYSIS, 2021–2030 (USD MILLION)
TABLE 4 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET TYPE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 5 MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 6 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET SPECIES ANALYSIS, 2016-2020, (USD MILLION)
TABLE 7 MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 8 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET DERIVATIVES ANALYSIS, 2016-2020, (USD MILLION)
TABLE 9 MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 10 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET END-USE ANALYSIS, 2016-2020, (USD MILLION)
TABLE 11 MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 12 GLOBAL MEDICAL CANNABIS HISTORICAL MARKET APPLICATION ANALYSIS, 2016-2020, (USD MILLION)
TABLE 13 MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 14 NORTH AMERICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 15 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 16 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 17 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 18 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 19 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 20 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2016–2021
TABLE 21 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 22 U.S. MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 23 CANADA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 24 CANADA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 25 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 26 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 27 APAC MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 28 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 29 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 32 ASIA-PACIFIC MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 33 CHINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 34 CHINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 35 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 36 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 37 KOREA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 38 KOREA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 39 INDIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 40 INDIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 41 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 42 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 43 MIDDLE EAST AND AFRICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 44 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 45 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 46 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 47 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 48 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 49 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 50 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 51 UAE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 52 UAE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 53 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 54 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 55 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 56 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 57 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 58 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 59 EUROPE MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 60 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 61 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 62 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 63 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 64 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 65 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 66 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 67 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 68 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 69 UK MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 70 UK MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 71 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 72 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 73 ITALY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 74 ITALY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 75 LATIN AMERICA MEDICAL CANNABIS HISTORICAL MARKET ANALYSIS, 2016-2020, (USD MILLION)
TABLE 76 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 77 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 78 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030 (USD MILLION)
TABLE 79 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030 (USD MILLION)
TABLE 80 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030 (USD MILLION)
TABLE 81 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 82 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 83 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 84 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
TABLE 85 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
TABLE 86 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 1 GLOBAL MEDICAL CANNABIS MARKET, 2021–2030, (USD MILLION)
FIGURE 2 RESEARCH METHODOLOGY
FIGURE 3 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 4 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET, 2021–2030, (USD MILLION)
FIGURE 5 MARKET OVERVIEW
FIGURE 6 SWOT ANALYSIS
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 SUPPLY CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 MEDICAL CANNABIS TYPE ANALYSIS
FIGURE 11 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 12 MEDICAL CANNABIS SPECIES ANALYSIS
FIGURE 13 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 14 MEDICAL CANNABIS DERIVATIVES ANALYSIS
FIGURE 15 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 16 MEDICAL CANNABIS END-USE ANALYSIS
FIGURE 17 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 18 MEDICAL CANNABIS APPLICATION ANALYSIS
FIGURE 19 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 20 GLOBAL MEDICAL CANNABIS CURRENT AND FUTURE MARKET VOLUME SHARE REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 21 MARKET OVERVIEW, REGIONAL ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 22 MARKET SHARE BY COUNTRY
FIGURE 23 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 24 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 25 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 26 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 27 NORTH AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 28 U.S. MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 29 U.S. MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 30 CANADA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 31 CANADA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 32 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 33 MEXICO MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 34 MARKET SHARE BY COUNTRY
FIGURE 35 APAC MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 36 APAC MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 37 APAC MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 38 APAC MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 39 APAC MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 40 CHINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 41 CHINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 42 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 43 JAPAN MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 44 KOREA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 45 KOREA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 46 INDIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 47 INDIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 48 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 49 SOUTHEAST ASIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 50 MARKET SHARE BY COUNTRY
FIGURE 51 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 52 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 53 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 54 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 55 MIDDLE EAST AND AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 56 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 57 SAUDI ARABIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 58 UAE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 59 UAE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 60 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 61 EGYPT MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 62 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 63 NIGERIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 64 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 65 SOUTH AFRICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 66 MARKET SHARE BY COUNTRY
FIGURE 67 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 68 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 69 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 70 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 71 EUROPE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 72 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 73 GERMANY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 74 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 75 FRANCE MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 76 UK MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 77 UK MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 78 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 79 RUSSIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 80 ITALY MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 81 ITALY MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 82 MARKET SHARE BY COUNTRY
FIGURE 83 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 84 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE SPECIES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 85 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE DERIVATIVES ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 86 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE END-USE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 87 LATIN AMERICA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 88 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 89 BRAZIL MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 90 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 91 ARGENTINA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 92 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE TYPE ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 93 COLUMBIA MEDICAL CANNABIS CURRENT AND FUTURE APPLICATION ANALYSIS, 2021–2030, (USD MILLION)
FIGURE 94 FINANCIAL OVERVIEW:
FAQ
Premium Report Details
Published On:5-Apr-22
Base Year:2024
Historical Data:2019
No of Pages:170
Buy Now
Need a Discount? Get in touch with us for special pricing
Connect with our sales team
Global Medical Cannabis Market- Industry Analysis,...
RD Code : HP22Subscribe Us
Sign up today for tips and latest news
and exclusive special offers.
